Cellular expression and siRNA-mediated interference of rhodopsin cis-acting splicing mutants associated with autosomal dominant retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3723-3729

  Hernan, Imma ^a   Gamundi, María José ^a   Planas, Ester ^a,b   Borrás, Emma ^a   Maseras, Miquel ^a   Carballo, Miguel ^a  

^a HOSPITAL DE TERRASSA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RHODOPSIN; SMALL INTERFERING RNA; MESSENGER RNA; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINITIS PIGMENTOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SPLICING; ALTERNATIVE RNA SPLICING; ANIMAL; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; DOMINANT GENE; GENETIC TRANSFECTION; GENETICS; HELA CELL; IMMUNOHISTOCHEMISTRY; MUTATION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENES, DOMINANT; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; MUTATION; RETINITIS PIGMENTOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODOPSIN; RNA INTERFERENCE; RNA SPLICING; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80051740905     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6933     Document Type: Article

References (38)

1. Will Cl, Lührmann R. Protein functions in pre-mRNA splicing. Cur Opin Cell Biol. 1997;9:320-328.
2. Burge CB, Tsuchl T, and Sharp PA. Splicing of precursors to mRNAs by the spliceosomes. The RNA World. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1999:525-560.
3. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet. 1992;90:41-54.
4. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3:285-298.
5. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003;17:419-437.
6. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-1809.
7. Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008;19:255-262.
8. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002;11:1219-1227.
9. Sullivan LS, Bowne SJ, Birch DG, et al. Prevalence of diseasecausing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006;47:3052-3064.
10. Millá E, Maseras M, Martínez-Gimeno M, et al. Genetic and molecular characterization of 148 patients with autosomal dominant retinitis pigmentosa (adRP) (in Spanish). Arch Soc Esp Oftalmol. 2002;77:480-484.
11. Reig C, Alvarez AI, Tejada I, et al. New mutation in the 3'-acceptor splice site of intron 4 in the rhodopsin gene associated with autosomal dominant retinitis pigmentosa in a Basque family. Hum Mutat. 1996;8:93-94.
12. Martínez-Gimeno M, Trujillo MJ, Lorda I, et al. Three novel mutations (P215L, T289P, and 3811-2 A>G) in the rhodopsin gene in autosomal dominant retinitis pigmentosa in Spanish families. Hum Mutat. 2000;16:95-96.
13. Rosenfeld PJ, Hahn LB, Sandberg MA, Dryja TP, Berson EL. Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation. Invest Ophthalmol Vis Sci. 1995;36:2186-2192.
14. Greenberg J, Roberts L, Ramesar R. A rare homozygous rhodopsin splice-site mutation: the issue of when and whether to offer presymptomatic testing. Ophthalmic Genet. 2003;24:225-232.
15. Gamundi MJ, Hernan I, Muntanyola M, et al. Transcriptional expression of cis-acting and trans-acting splicing mutations cause autosomal dominant retinitis pigmentosa. Hum Mutat. 2008;29: 869-878.
16. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A. 2003;100:189-192.
17. Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol. 2004;5:89-99.
18. Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem. 2007;76:51-74.
19. Rio Frio T, Wade NM, Ransijn A, Berson EL, Beckmann JS, Rivolta C. Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest. 2008;118:1519-1531.
20. Abu-Safieh L, Vithana EN, Mantel I, et al. A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease. Mol Vis. 2006;12:384-388.
21. Rivolta C, McGee TL, Rio Frio T, Jensen RV, Berson EL, Dryja TP. Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations. Hum Mutat. 2006;27:644-653.
22. Wilkie SE, Vaclavik V, Wu H, et al. Disease mechanism for retinitis pigmentosa (RP11) caused by missense mutations in the splicing factor gene PRPF31. Mol Vis. 2008;14:683-690.
23. Jacobson SG, Kemp CM, Cideciyan AV, Macke JP, Sung CH, Nathans J. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1994;35:2521-2534.
24. Rosenfeld PR, Cowley GS, McGee TL, Sandberg MA, Berson EL, Dryja TP. A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet. 1992;1:209-213.
25. Rajan RS, Kopito RR. Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J Biol Chem. 2005;280:1284-1291.
26. Mendes HF, Cheetham ME. Pharmacological manipulation of gainof-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa. Hum Mol Genet. 2008;17:3043-3054.
27. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806-811.
28. Miller VM, Xia H, Marrs GL, et al. Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci U S A. 2003;100:7195-7200.
29. Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS ONE. 2008;3:e2248.
30. Carter MS, Doskow J, Morris P, et al. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem. 1995;270:28995-29003.
31. Zhang J, Sun X, Qian Y, Maquat LE. Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that premRNA splicing in the nucleus can influence mRNA translation in the cytoplasm. RNA. 1998;4:801-815.
32. Martin SE, Caplen NJ. Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet. 2007;8:81-108.
33. Humphries MM, Rancourt D, Farrar GJ, et al. Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet. 1997;15:216-219.
34. Palfi A, Ader M, Kiang AS, et al. RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture. Hum Mutat. 2006;27:260-268.
35. Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. Vision Res. 2007;47:1202-1208.
36. Grimm D, Kay MA. A combinatorial RNAi: a winning strategy for the race against evolving targets? Mol Ther. 2007;15:878-888.
37. O'Reilly M, Palfi A, Chadderton N, et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet. 2007;81:127-135.
38. O'Reilly M, Millington-Ward S, Palfi A, et al. A transgenic mouse model for gene therapy of rhodopsin-linked retinitis pigmentosa. Vision Res. 2008;48:386-391.